LRCX Hold: Knife-edge binary technical setup with $250 hard stop and $285 conditional add trigger
HOLD verdict reconciles balanced debate where Aggressive Analyst's structural quality case (65% ROE, 30% revenue growth, forward P/E 23x, net cash, sold-out backlog, MACD higher-low at -10.69 vs July's -19.16) is real, but Conservative Analyst wins on three execution-discipline points: (1) MACD histogram at -3.73 is widening, not narrowing, confirming downside momentum acceleration; (2) FCF margin of 13.3% sits below historical mid-cycle norms of 18-22% for two consecutive quarters; (3) 2027 order book has unresolved risks including HBM5 uncommitted, Samsung restructuring memory output, and SK Hynix cautious guidance into 2H27. Hard stop at $250 below 200 SMA ($266) and July $252.35 low; $285 retest on hold above $266.
| Position | Action |
|---|---|
| Current positioning | Maintain neutral weight (3-5% of portfolio) with no fresh buying at $269.31 levels |
| Confirmed close above $285 (10 EMA) with RSI > 45 and rising MACD | Add 30-40% position |
| Close below $264 with elevated volume | Trim 50% position |
| Q3 FY27 revenue miss vs $6.85-7.0B consensus by >5% OR any customer capex guidance cut | Exit position |
The 38.6% selloff in LRCX is a sentiment shock disconnected from fundamentals—the company is in the early-to-mid phase of a powerful upcycle with five consecutive quarters of sequential revenue improvement, expanding margins, a net cash balance sheet, and a deepening competitive moat in HBM4 and GAA architectures that makes this a buying opportunity at forward P/E 23.11x.
| Indicator | Value | Signal |
|---|---|---|
| Close | 269.31 | neutral |
| 10 EMA | 285.75 | bearish |
| 50 SMA | 308.68 | bearish |
| 200 SMA | 266.34 | neutral |
| MACD Line | -10.69 | bearish |
| MACD Signal | -6.95 | bearish |
| MACD Histogram | -3.73 | bearish |
| RSI | 36.08 | neutral |
| ATR(14) | 15.58 | neutral |
| VWMA(20) | 291.98 | bearish |
| Bollinger Lower Band | 264.65 | neutral |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Close below $264 with elevated volume
Then: Trim 50% position
Technical setup shows a coiled spring at long-term support, not a breakdown—bullish divergences are forming
↩ rebuts: “The technicals are broken”
EV: +23% to +44% · concedes: Stock is at a critical technical pivot—a close below $266 on volume opens the door to $252 and $237; Beta of 1.86 and ATR of $15.58 mean position sizing matters; Wait for confirmation on a close above the 10 EMA at $285.75 with RSI > 45 before adding size
LRCX at $269 is a late-cycle positioning trap where consensus estimates will be cut once the AI-pacing narrative metastasizes into actual 2027 capex restraint, memory capex rolls over, working capital reverses, and FCF deteriorates — triggering a 40-60% semi-cap drawdown similar to 2021-2023.
EV: -$252 (base case) → $237 → $200 (downside 10-25%) · concedes: LRCX has net cash of $1.85B — that's real; The business is great — at peak; The bull's math is internally consistent
→ vs conservative: The conservative 'wait for confirmation above 10 EMA at $285' approach is strategy lazy and guarantees buying $16 higher with momentum already extended; by the time trend confirms, the easy money is gone
→ vs conservative: The conservative framing of 'maintain neutral weight at 3 to 5 percent until trend confirms' is exactly the discipline that underperforms during regime changes; strongest trend signals come right after shakeouts like the 38% correction from June peak
→ vs neutral: The trader's bear case on MACD divergence being flawed because there's 'no lower low' is technical nitpicking missing the forest for the trees; price at major long-term support with momentum divergence confirms is textbook launchpad
→ vs neutral: FCF margin concern at 13.3% being 'below historical mid-cycle norms of 18 to 22 percent' is misdiagnosed as structural deterioration when it's actually temporary working capital absorption; operating cash flow suppressed by $860-875 million tied to demand ramping
→ vs neutral: The '2027 order book uncertainty' concern misses that forward P/E of 23x already discounts HBM5 uncertainty; market has repriced the risk and investors get 34% EPS growth at PEG of 1.25
→ vs neutral: Treating 200 SMA at $266 as knife-edge binary risk with equal probability of breaking to $252/$237 versus bouncing to $285 underestimates the evidence favoring bounce; recession odds are only 10% and Fed policy is hawkish-stable
| Bollinger Middle Band | 298.92 | neutral |
| Bollinger Upper Band | 333.19 | neutral |
Support: 264.65 · 266.34 · 252.35 · 237 | Resistance: 269.31 · 285.75 · 298.92 · 308.68 · 333.19
LRCX has collapsed from a June 2026 peak of $438.50 to $269.31 (down ~38.6%), with price sitting just above the critical 200-day SMA at $266.34. All short- and medium-term moving averages (10 EMA at $285.75, 50 SMA at $308.68) are well above current price, confirming a bearish alignment. MACD is deeply negative at -10.69 with a widening histogram of -3.73, RSI sits at 36.08 approaching the 30 oversold threshold, and VWMA at $291.98 confirms institutional distribution. A notable bullish divergence exists between price and MACD (price made lower lows while MACD made higher lows), offering a potential bottoming signal if confirmed. ATR has compressed to 15.58 from a peak of 24.86, suggesting volatility is contracting—a late-stage decline characteristic. Key levels: Bollinger Lower Band at $264.65, 200 SMA critical pivot at $266.34, first resistance at 10 EMA $285.75, and heavy supply at 50 SMA $308.68.
Market Capitalization
$337.0 billion
52-Week Range
$125.00 – $438.50
Beta
1.859
Dividend Yield
0.49%
Share Count (Diluted)
~1.251 billion
TTM Revenue
$23.23 billion
Q2 2026 Revenue
$6.72B
Q2 2026 Annualized Run Rate
~$26.9 billion
Gross Margin (Q2 2026)
~51.7%
Operating Margin (TTM)
37.4%
Operating Income (Q2 2026)
$2.51B
Net Income (Q2 2026)
$2.28B
Diluted EPS (Q2 2026)
$1.81
Normalized EBITDA (Q2 2026)
$2.72B
Total Assets
$23.53B
Cash & Equivalents
$5.58B
Total Debt
$3.73B
Stockholders' Equity
$12.47B
Working Capital
$9.67B
Inventory
$4.28B
Accounts Receivable
$5.34B
Net Debt
~$1.85B (cash exceeds debt)
Current Ratio
2.63
TTM Free Cash Flow
$3.09 billion
TTM FCF Margin
~13.3%
Q2 2026 FCF
$1.27B
Q2 2026 CapEx
$189M
Q2 2026 Buybacks
$246M
TTM Buybacks
~$3.6B
Quarterly Dividend
~$325M
Debt Repaid (Q1 2026)
$751M
P/E (TTM)
46.76x
Forward P/E
23.11x
PEG Ratio
1.25
Price/Book
27.02x
ROE
65.07%
ROA
22.84%
Debt/Equity
~33.0%
TTM Net Income
$7.27B
TTM EBITDA
$8.64B
Profit Margin
31.3%
Forward EPS
$11.65
Implied Forward Multiple
~23x
Implied Fair Value
~$270/share
Revenue Growth (Q2 2026 YoY)
+30.0%
Operating Income Growth (Q2 2026 YoY)
+44.4%
Net Income Growth (Q2 2026 YoY)
+32.4%
Diluted EPS Growth (Q2 2026 YoY)
+34.1%
Strengths
Concerns
Lam Research Corporation (LRCX) is a leading global supplier of semiconductor wafer fabrication equipment specializing in deposition (CVD/ALD), etch, and clean/strip processes, serving the world's major memory (DRAM, NAND) and logic/foundry chipmakers. The company is in the early-to-mid phase of a semiconductor capex upcycle, with Q2 2026 revenue of $6.72B representing 30% YoY growth and margins expanding to 51.7% gross and 37.4% operating — a classic operating leverage signature. The fortress balance sheet ($1.85B net-cash) enables aggressive capital returns (~$3.6B TTM in buybacks), while best-in-class ROE of 65% and ROA of 22.8% reflect a durable competitive moat in etch-intensive AI-driven semiconductor manufacturing. However, the TTM P/E of 46.76x appears rich versus a forward P/E of 23.11x, with high cyclicality (beta 1.86), customer concentration, and geopolitical/export control risks warranting position-sizing discipline; the stock is best suited for trend-following momentum strategies during upcycles and defensive trims when leading indicators roll over.
Macro: The Fed is in a hiking/stay-high posture with 95% Polymarket probability of no Fed cuts in 2026 (+2.6pp over the past week), with zero probability for 6+ cuts. US recession odds are low at 10% (+2.0pp wk), alongside 10% UK and 6% Japan. Industrial policy scenarios show modest probability: TSMC 16%, NVIDIA 12%, Anduril 17%. Jamie Dimon has warned 'it's not clear to me we've slayed inflation.' 10Y yield 'eased' per AlphaCheck while oil fell to ~$100, which is mildly bullish for long-duration tech.